Breaking News
October 21, 2017 - New Genes Linked to Restless Legs Syndrome
October 21, 2017 - No relief in sight for those suffering from sciatica
October 21, 2017 - 'This Is About Saving Lives': What We Heard This Week
October 21, 2017 - 3 Million Americans Say They Carry Handguns Every Day
October 21, 2017 - Night shift work linked to an increased risk of obesity
October 21, 2017 - Avoiding Alcohol Helps the Heart Beat Better
October 21, 2017 - Exposure to heavy metals may increase risk of autism
October 21, 2017 - Derms: Oral Contraceptives as Acne Tx Warrant Caution
October 21, 2017 - How Foods Labeled 'Healthy' Can Still Make You Fat
October 21, 2017 - ALS patient behind ice bucket challenge: I will bounce back
October 21, 2017 - FDA Advisory Committee Unanimously Recommends Approval of Investigational Luxturna (voretigene neparvovec) for Patients with Biallelic RPE65-mediated Inherited Retinal Disease
October 21, 2017 - Household bleach may raise chronic lung disease risk
October 21, 2017 - Patient Care vs Primary Care: Is There a Problem Here?
October 21, 2017 - State Laws Help Reduce Concussions in Youth Sports
October 21, 2017 - Study indicates proof of concept for using a surrogate liquid biopsy to provide genetic profile of retinoblastoma tumors
October 21, 2017 - Story-based videos hold promise for encouraging Latinas to seek help for anxiety and depression
October 21, 2017 - Study identifies predictors of poor outcomes in Duchenne muscular dystrophy patients
October 21, 2017 - New study explores how herpes simplex virus may change during familial transmission
October 21, 2017 - Researchers analyze frequency of mislabeling in herbal and dietary supplements
October 21, 2017 - Direct‐acting antiviral therapy linked to 71% reduction in liver cancer risk
October 21, 2017 - NAFLD linked to higher cardiovascular risk in women, but not in men
October 21, 2017 - Study finds increasing health care costs for patients with alcoholic cirrhosis
October 21, 2017 - Liver cirrhosis mortality found to be greater than that of five major cancers
October 21, 2017 - VUMC reaches new milestone after performing 2,000th liver transplant
October 21, 2017 - Study examines risk of using liver organs from hepatitis C positive donors
October 21, 2017 - Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer
October 21, 2017 - Increased use of split liver transplantation could decrease pediatric waitlist deaths
October 21, 2017 - HCV screening or diagnosis could lower non‐prescribed opioid use
October 21, 2017 - Schizophrenia Affects Brain's Communication Network
October 21, 2017 - Serum metabolites linked to NAFLD may be heritable, research shows
October 21, 2017 - Pneumoconiosis: Symptoms, risk factors, and management
October 21, 2017 - Study finds rise in pregnancy rates among women with chronic liver disease
October 21, 2017 - 1 in 5 Young Women Who Tan Indoors Get Addicted
October 21, 2017 - Stent Outcomes Not So Different Across Sexes, Races
October 21, 2017 - Eyebank corneal tissue prep may increase infection risk
October 21, 2017 - Researchers use nanopore technique to detect biomarkers of disease
October 21, 2017 - UC San Diego researchers develop 3D visualization tool for mapping omics data onto organs
October 21, 2017 - Umass Amherst scientist receives grant to study pollutant effects on embryos in animal models
October 21, 2017 - Study finds rising incidence of IBD in newly industrialized countries
October 21, 2017 - Researchers use novel imaging technique for precise assessment of spinal degeneration
October 21, 2017 - Penn State receives federal grant to improve services for children with complex communication needs
October 21, 2017 - New synthetic genetic tool measures and manipulates protein aggregation in live cells
October 21, 2017 - Introduction of childbirth guide results in fewer stillbirths at East African hospital
October 21, 2017 - New vaccine for pneumonia holds promise to save thousands of lives
October 21, 2017 - Study provides deeper understanding on mechanisms of lipid-based autoimmune disease
October 21, 2017 - Pharmacological stimulation of nicotinic receptor could be strategy to treat lung inflammation
October 20, 2017 - Parents with alcohol use disorder increase risk for teen dating violence
October 20, 2017 - Inventiva’s Phase IIb FASST Trial in Systemic Sclerosis with Lanifibranor Completes Enrollment
October 20, 2017 - Torn meniscus: Causes, symptoms, and recovery
October 20, 2017 - Post-Mastectomy Breast Reconstruction Gains Ground
October 20, 2017 - Self-Harm on the Rise Among Teen Girls
October 20, 2017 - Mice delivered by C-section gain more weight than those delivered naturally
October 20, 2017 - Novo Nordisk Receives Positive 16-0 vote from FDA Advisory Committee in Favor of Approval for Semaglutide
October 20, 2017 - Shy bladder: Causes and treatments
October 20, 2017 - Obese Kids with Asthma at Higher Risk for Hospital Readmission
October 20, 2017 - Could Too Much Exercise Be Bad for Men's Hearts?
October 20, 2017 - Oxidative stress produces damage linked with increased risk of preterm birth
October 20, 2017 - Gene circuit can be used to switch on inside cancer cells and stimulate immune attack, study suggests
October 20, 2017 - Health Tip: Best Grains And Starchy Veggies for Diabetics
October 20, 2017 - Alzheimer's could be diagnosed early with sniff tests
October 20, 2017 - CardioBrief: Imaging Offers Insight Into Inflammation in CV Disease
October 20, 2017 - More Young Kids Spending Lots of Time on Phones, Tablets
October 20, 2017 - Study provides insights into how amygdala regulates emotions and social behavior
October 20, 2017 - Chromosomes may be entangled, research finds
October 20, 2017 - Experts create quality improvement blueprint to reduce repetitive lab tests for hospitalized patients
October 20, 2017 - Researchers discover new function in gene-regulatory protein
October 20, 2017 - Findings suggest e-cigarettes may be just as bad as traditional cigarettes
October 20, 2017 - Adipose-derived stem cell clinical trial focuses on non-healing leg wounds
October 20, 2017 - Incysus Announces FDA Approval of IND Application for a Phase I Study of a Gamma-Delta (γδ) T Cell Leukemia and Lymphoma Immunotherapy
October 20, 2017 - Dust mite allergy: Symptoms, treatment, and prevention
October 20, 2017 - FDA's Patient Engagement Committee Launches
October 20, 2017 - Arthritis Can Strike Children
October 20, 2017 - Study shows people find well-being more so from special places than from mementoes
October 20, 2017 - Suspected plague cases from Seychelles tested negative at WHO partner laboratory
October 20, 2017 - UGA researchers pinpoint factors that drive sharp rise in breast cancer genetic testing
October 20, 2017 - New study reveals extensive healthcare costs that result from acute kidney injury
October 20, 2017 - Amid for-profit surge, rural hospice has offered free care for 40 years
October 20, 2017 - Teens' increased use of electronic devices linked to rise in insufficient sleep
October 20, 2017 - Delayed word processing could indicate MCI patients’ likelihood of developing Alzheimer's
October 20, 2017 - Researchers reveal how certain nerves sustain prostate cancer growth
Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

image_pdfDownload PDFimage_print

Bottom Line: New potential biomarkers and a novel algorithm could help identify patients at increased risk of suffering from severe neurotoxicity after receiving CD19 CAR T-cell therapy. The study extensively characterized common and occasionally fatal side effects of this immunotherapy.

Journal in Which the Study was Published: Cancer Discovery, a journal of the American Association for Cancer Research.

Authors: Cameron J. Turtle, MBBS, PhD, associate member at Fred Hutchinson Cancer Research Center, associate professor at the University of Washington, and attending physician on the Immunotherapy Service at Fred Hutch.

Background: On August 30, 2017, the FDA approved the first CD19 CAR T-cell therapy, tisagenlecleucel (Kymriah), for the treatment of acute lymphoblastic leukemia (ALL) in certain pediatric and young adult patients. Different CD19 CAR T-cell therapies are being developed and tested, and reports show that a small number of patients who received certain forms of this therapy in clinical trials have died from severe neurotoxicity.

Turtle and colleagues sought to provide a detailed clinical, radiological, and pathological characterization of neurotoxicity arising from CD19 CAR T-cell therapy.

How the Study Was Conducted: The researchers used data from a clinical trial in which 133 adult patients with relapsed and/or refractory CD19 B-cell ALL, non-Hodgkin lymphoma or chronic lymphocytic leukemia were treated with lymphodepletion chemotherapy followed by infusion of JCAR014, a type of CD19 CAR T-cell therapy developed at Fred Hutchinson Cancer Research Center.

Within 28 days of treatment, 53 patients (40 percent) developed grade 1 or higher neurologic adverse events and of these 28 (21 percent) had grade 3 or higher neurotoxicity; alterations in neurologic status completely resolved in a majority of cases. Four of the 133 patients (3 percent) developed fatal neurotoxicity.

Results: Turtle and colleagues found that patients with an early onset of CRS were at increased risk of subsequently developing severe neurotoxicity. While tocilizumab (Actemra), an IL-6R antagonist approved by the FDA to treat CRS, was effective in ameliorating CRS-related fever and hypotension in most patients, the team found that its role in preventing or treating neurotoxicity is less clear.

Patients who experienced neurotoxicity were mostly younger and had B-cell ALL, higher tumor burden, and more CD19-positive cells in the bone marrow, compared with those who did not develop this side effect. Data also revealed that those with severe neurotoxicity had endothelial activation, which could contribute to manifestations such as capillary leak, blood coagulation abnormalities, and disruption of the blood-brain barrier that were observed in patients with severe CRS and neurotoxicity.

Turtle and colleagues developed a predictive classification tree algorithm based on the side effects, including fever, and high serum IL-6 and MCP-1, to identify patients, within the first 36 hours after CAR T-cell infusion, who are at increased risk for severe neurotoxicity. Patients at increased risk for this adverse event may benefit from early intervention, Turtle noted; however, he pointed out that additional studies are required.

Authors’ Comments: “CD19 CAR T-cell therapy is a highly effective, novel treatment modality that has rapidly expanded in the cancer research and treatment field over the past few years, including recent approval of one form of this therapy by the U.S. Food and Drug Administration [FDA],” said Turtle.

“There is understandably anxiety about some of the side effects of CD19 CAR T-cell therapy, but these treatments have been very effective for a subgroup of patients with resistant disease,” he said. “It is important to understand the side effects, such as cytokine release syndrome [CRS] and neurological toxicity.”

Enormous improvements have been made in the last few years in strategies to minimize the risk of toxicity, Turtle noted. “Because CAR T-cell therapy is so new, we are still learning how to improve the delivery and reduce the side effects,” he added.

Limitations: Limitations of the study include that the characterization of side effects was only from patients who received JCAR014 and not other forms of CD19 CAR T-cell therapies, Turtle said.

Tagged with:

About author

Related Articles